Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3177023)

Published in Drug Alcohol Depend on April 27, 2011

Authors

Bruce Rasmussen1, Ellen M Unterwald, Scott M Rawls

Author Affiliations

1: Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA.

Articles citing this

Glutamate transporter 1: target for the treatment of alcohol dependence. Curr Med Chem (2012) 1.09

Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend (2013) 0.94

Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Res (2012) 0.94

Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Neuropharmacology (2015) 0.93

Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol. Psychopharmacology (Berl) (2015) 0.89

Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice. Neurosci Lett (2013) 0.87

Biotic acts of antibiotics. Front Microbiol (2013) 0.86

The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis. Pharmacol Rev (2016) 0.86

Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury. Neurol Sci (2013) 0.85

Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance. Neuroreport (2011) 0.84

Changing motives for use: outcomes from a cognitive-behavioral intervention for marijuana-dependent adults. Drug Alcohol Depend (2014) 0.83

Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice. Amino Acids (2015) 0.81

Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? Drug Alcohol Depend (2014) 0.81

Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets (2015) 0.80

Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo. Neuropharmacology (2014) 0.79

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism. Neurosci Lett (2012) 0.78

Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology (2016) 0.77

Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats. Drug Alcohol Depend (2015) 0.76

Designing Novel Nanoformulations Targeting Glutamate Transporter Excitatory Amino Acid Transporter 2: Implications in Treating Drug Addiction. J Pers Nanomed (2015) 0.76

Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus. J Mol Neurosci (2016) 0.75

Articles cited by this

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature (2005) 7.19

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) (2000) 5.19

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci (2003) 4.63

Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci (1996) 3.66

Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci (2005) 3.08

Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06

Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry (2010) 2.60

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience (2008) 2.31

Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci (2009) 2.05

Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience (2007) 1.80

Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation. Stroke (2006) 1.74

Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci (2010) 1.64

The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res (1975) 1.55

Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci (1989) 1.49

Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport (1996) 1.27

Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behav Brain Res (2005) 1.18

Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res (1995) 1.17

Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend (2009) 1.15

β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids (2010) 1.11

Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) (1997) 1.07

Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats. J Neurochem (2010) 1.07

Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem (1996) 1.02

Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res (1991) 0.97

The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol (2008) 0.97

beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behav Pharmacol (2010) 0.97

Cocaine increases medial prefrontal cortical glutamate overflow in cocaine-sensitized rats: a time course study. Eur J Neurosci (2004) 0.96

Microdialysis and the neurochemistry of addiction. Pharmacol Biochem Behav (2007) 0.95

Inhibition of non-vesicular glutamate release by group III metabotropic glutamate receptors in the nucleus accumbens. J Neurochem (2003) 0.90

Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats. Eur J Pharmacol (2009) 0.89

Ion channel modulation as the basis for neuroprotective action of MS-153. Ann N Y Acad Sci (1999) 0.88

DNQX blockade of amphetamine behavioral sensitization. Brain Res (1991) 0.88

Effects of repeated cocaine on medial prefrontal cortical GABAB receptor modulation of neurotransmission in the mesocorticolimbic dopamine system. J Neurochem (2004) 0.87

Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res (1990) 0.81

Metabotropic glutamate receptors are necessary for sensitization by amphetamine. Neuroreport (1998) 0.80

Articles by these authors

Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend (2012) 1.37

In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther (2004) 1.30

Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat. Neuropharmacology (2007) 1.28

Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br J Pharmacol (2006) 1.27

2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A. J Pharmacol Exp Ther (2007) 1.22

D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration. J Pharmacol Exp Ther (2005) 1.13

β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids (2010) 1.11

Cocaine-induced hyperactivity and sensitization are dependent on GSK3. Neuropharmacology (2009) 1.08

Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology (2009) 1.07

Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behav Pharmacol (2011) 1.06

D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. J Cell Physiol (2002) 1.05

Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine. J Neurosci (2002) 1.03

Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res (2007) 0.99

Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br J Pharmacol (2014) 0.99

Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. J Pharmacol Toxicol Methods (2010) 0.95

Intrahypothalamic injection of deltorphin-II alters body temperature in rats. Brain Res (2004) 0.95

Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptor. Biochem Biophys Res Commun (2007) 0.95

Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend (2013) 0.94

Age-specific behavioral responses to psychostimulants in mice. Pharmacol Biochem Behav (2005) 0.92

Cocaine regulates protein kinase B and glycogen synthase kinase-3 activity in selective regions of rat brain. J Neurochem (2008) 0.91

Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain. Synapse (2003) 0.91

Icilin induces a hyperthermia in rats that is dependent on nitric oxide production and NMDA receptor activation. Eur J Pharmacol (2007) 0.91

A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat. Psychopharmacology (Berl) (2007) 0.91

Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats. Behav Pharmacol (2013) 0.90

Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain Res Bull (2010) 0.90

A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors. Psychopharmacology (Berl) (2010) 0.90

Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice. Neurosci Lett (2009) 0.90

Serotonin (2C) receptor regulation of cocaine-induced conditioned place preference and locomotor sensitization. Behav Brain Res (2012) 0.90

The distribution of cocaine in mice differs by age and strain. Neurotoxicol Teratol (2004) 0.89

Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal. Am J Pathol (2012) 0.89

Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians. Physiol Behav (2013) 0.88

Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens. Brain Res (2008) 0.87

Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice. Neurosci Lett (2013) 0.87

Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors. Brain Res (2009) 0.87

Mu and kappa opioid receptor agonists antagonize icilin-induced wet-dog shaking in rats. Eur J Pharmacol (2006) 0.86

The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Res (2007) 0.85

Glutamate transporter activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance. Neuroreport (2011) 0.84

Intra-accumbens pertussis toxin sensitizes rats to the locomotor activating effects of a single cocaine challenge. Brain Res (2003) 0.84

Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. Synapse (2009) 0.83

Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. Behav Brain Res (2012) 0.83

Behavioral sensitization to binge-pattern cocaine administration is not associated with changes in protein levels of four major G-proteins. Brain Res Mol Brain Res (2005) 0.82

Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition. Psychopharmacology (Berl) (2014) 0.82

Localization of CXCR4 in the forebrain of the adult rat. Brain Res (2009) 0.82

Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neurosci Lett (2008) 0.81

Augmented D1 dopamine receptor signaling and immediate-early gene induction in adult striatum after prenatal cocaine. Biol Psychiatry (2008) 0.81

Topiramate-antagonism of L-glutamate-induced paroxysms in planarians. Eur J Pharmacol (2010) 0.80

Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. Psychopharmacology (Berl) (2009) 0.80

Novel C-1 substituted cocaine analogs unlike cocaine or benztropine. J Pharmacol Exp Ther (2012) 0.80

Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide production. Pharmacol Biochem Behav (2009) 0.80

Trk: a neuromodulator of age-specific behavioral and neurochemical responses to cocaine in mice. J Neurosci (2008) 0.80

Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians. Behav Pharmacol (2016) 0.79

Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity. Neuropharmacology (2009) 0.79

Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. Pharmacol Biochem Behav (2009) 0.79

Cocaine decreases expression of neurogranin via alterations in thyroid receptor/retinoid X receptor signaling. J Neurochem (2012) 0.78

Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism. Brain Res (2009) 0.78

Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum. Neuropharmacology (2006) 0.78

Repeated intracerebroventricular forskolin administration enhances behavioral sensitization to cocaine. Behav Brain Res (2004) 0.78

In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism. Neurosci Lett (2012) 0.78

Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats. Pharmacol Biochem Behav (2009) 0.78

Repeated cocaine enhances ventral hippocampal-stimulated dopamine efflux in the nucleus accumbens and alters ventral hippocampal NMDA receptor subunit expression. J Neurochem (2014) 0.77

Behavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons. Mol Neurodegener (2013) 0.77

NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens. J Neurochem (2010) 0.77

Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity. Pharmacol Biochem Behav (2004) 0.77

Methanandamide blocks amphetamine-induced behavioral sensitization in rats. Eur J Pharmacol (2009) 0.76

Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay. Amino Acids (2011) 0.76

Activity-regulated gene expression in immature neurons in the dentate gyrus following re-exposure to a cocaine-paired environment. Hippocampus (2014) 0.75

Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation. Brain Res (2011) 0.75

Introduction to the College on Problems of Drug Dependence special issue: contemporary advances in opioid neuropharmacology. Drug Alcohol Depend (2010) 0.75

Capsaicin evokes hypothermia independent of cannabinoid CB1 and CB2 receptors. Brain Res (2005) 0.75

5-HT reuptake and 5-HT2 receptors modulate capsaicin-evoked hypothermia in rats. Neurosci Lett (2007) 0.75

Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy. Neurosci Lett (2006) 0.75

Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model. Pharmacol Biochem Behav (2013) 0.75

Effects of ceftriaxone on conditioned nicotine reward in rats. Behav Pharmacol (2017) 0.75

KCNQ2/3 channel agonist flupirtine reduces cocaine place preference in rats. Behav Pharmacol (2017) 0.75